ConductScience.org, home

Gene · 10406

Papers3,333

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

161 to 180 of 3,333

Download this page as JSON
TitleJournalYearPMIDFound bySource
Comparative study of Exosome Ovarian Cancer auxiliary diagnostic kit (Chemiluminescence) and Serum Tumor Marker CA125 in the diagnosis of Ovarian Epithelial Cell Carcinoma.Pak J Med Sci202541394359PubTator, text miningPubMed
Ovarian Tumor Biomarkers: Correlation Between Tumor Type and Marker Expression, and Their Role in Guiding Therapeutic Strategies.Int J Mol Sci202541373846PubTator, text miningPubMed
SIDISH integrates single-cell and bulk transcriptomics to identify high-risk cells and guide precision therapeutics through in silico perturbation.Nat Commun202541372157PubTator, text miningPubMed
Plasma Proteomics Reveals Biomarkers and Undulating Changes in Metabolic Aging.Research (Wash D C)202541356597PubTator, text miningPubMed
Correlation Analysis of Serum Inhibin B, Endothelin, Human Epididymal Secretory Protein 4 and Sperm Quality in Patients with Varicocele.Arch Esp Urol202541339238PubTator, text miningPubMed
Explainable Artificial Intelligence for Ovarian Cancer: Biomarker Contributions in Ensemble Models.Biology (Basel)202541300279PubTator, text miningPubMed
Utility of HE4 in the Evaluation of Adnexal Masses Among Premenopausal and Postmenopausal Women.Indian J Surg Oncol202541283136PubTator, text miningPubMed
An assisted diagnostic and prognostic model for endometrial cancer using 36 serological markers and clinical variables from 562 patients.Sci Rep202541253880PubTator, text miningPubMed
A novel serum-based steroid-protein panels for differentiating ovarian cancer from non-malignant adnexal masses.Cancer Cell Int202541250090PubTator, text miningPubMed
Serum miR-200c-3p and miR-6134 as diagnostic biomarkers for epithelial ovarian cancer.Discov Oncol202541249738PubTator, text miningPubMed
Added value of serum proteins to clinical and ultrasound information in predicting the risk of malignancy in ovarian tumors.iScience202541210975PubTator, text miningPubMed
Smartphone-Enabled Electrochemical Biosensor for Simultaneous Detection of Cancer Biomarkers Using f-WS2@AuNPs Screen-Printed Electrodes.ACS Appl Bio Mater202541184081PubTator, text miningPubMed
Early detection of recurrent ovarian cancer, current use of oncomarkers, imaging methods, and future perspectives.Ceska Gynekol202541182876PubTator, text miningPubMed
Utility of a Multimodal Biomarker Panel and Serum Proapoptotic Activity to Refine Diagnosis of Ovarian Adnexal Masses.Diseases202541149076PubTator, text miningPubMed
Clinical Utility of the REM Score in Stratifying Endometrial Malignancy Risk: Insights From a Tertiary Care Centre in South India.J Obstet Gynaecol Res202541120180PubTator, text miningPubMed
Enhanced efficacy and safety of combining Aidi injection with megestrol acetate for endometrial cancer treatment.Am J Transl Res202541113060PubTator, text miningPubMed
Clinical Value of Vascular Cancer Thrombus and Myometrial Invasion Combined with Tumor Markers in Predicting Sentinel Lymph Node Metastasis of Endometrial Cancer.Cancer Manag Res202541103505PubTator, text miningPubMed
Combined Biomarker Panel of Presepsin, HE4, and Oxygenation Index for Sepsis Diagnosis and Prognosis in Intensive Care Unit Patients.J Inflamm Res202541098681PubTator, text miningPubMed
Systemic Immune and Tumor Marker Profiles in Ovarian and Deep Infiltrating Endometriosis: Associations with Disease Severity and Symptom Burden.Int J Mol Sci202541096846PubTator, text miningPubMed
Genetic investigation of sinopulmonary diseases in Vietnam: seeking specific causes from non-specific symptoms.Orphanet J Rare Dis202541094464PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/10406/papers?page=9